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Abstract
Background: Protocol-based resuscitation strategies in the Emergency Depart-
ment (ED) improve survival for out-of-hospital cardiac arrest (OHCA) and severe
sepsis but implementation has been inconsistent.
Objective: To determine the feasibility of a real-time provider-to-provider
telemedical intervention for the treatment of OHCA and severe sepsis.
Materials and methods: A three-center pilot study utilizing a “hub-spoke model”
with an academic medical center acting both as the hub for teleconsultation as well
as a spoke hospital enrolling patients. Eligible patients were adults presenting with
either return of spontaneous circulation (ROSC) following OHCA or with severe
sepsis. Telemedical encounters were monitored for quality of interface and patient
level data (demographics, physiologic, laboratory, treatment) were abstracted.
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Results: Over a 12-week period, there were 80 text alerts. Of 38 OHCA alerts, 13
achieved ROSC (34.2%), 85% underwent teleconsultation (11/13). Of 42 “lactate
≥4 mmol/L” alerts, 33.3% (14/42) were determined to have severe sepsis and
underwent teleconsultation. Mean time from OHCA teleconsultation request to live
connection: 3.7 min (95% CI 1.6–5.8); mean call duration: 71.7 min (95% CI
34.6–108.8). Mean time from sepsis teleconsultation request to connection: 8.4 min
(95% CI 4.5–12.3); mean call duration: 61.5 min (95% CI 37.2–85.8).
Discussion: Telemedicine provides a robust and reliable means of quickly bringing
expertise virtually to the bedside at the most proximal point in a patient’s hospital
care.
Conclusions: Real time ED-based telemedical consultation for patients with
ROSC after OHCA or severe sepsis has the potential to improve the dissemination
and implementation of evidence-based care.
Keywords: Health sciences, Medicine
1. Introduction
The optimal treatment of critical illness and injury was a driving force behind the
development of the field of emergency medicine and continues to define its
maturation as a medical subspecialty. Cardiac arrest represents a leading cause of
death in the United States; with out-of-hospital cardiac arrest (OHCA) affecting
some 300,000 citizens each year and producing roughly 40,000 victims requiring
post-arrest care [1, 2, 3]. After achieving return of spontaneous circulation
(ROSC), rapidly deployed, medically sophisticated interventions can impact
outcomes, providing substantial survival and neurologic outcomes benefit [2] [3].
Severe sepsis is the 11th leading cause of death, affecting over 750,000 patients per
year and accounting for roughly $17 billion of healthcare spending annually [4]
[5]. Rapid identification of severe sepsis using serum lactate [6] and initiation of
protocolized care, the most well-known form of which is Early Goal-Directed
Therapy (EGDT), can prevent sudden cardiovascular collapse and progression to
multi-organ dysfunction syndrome [7] [8].
Protocol-based resuscitation algorithms have been demonstrated to improve
survival for OHCA and severe sepsis [2] [3] [8, 9, 10, 11, 12]. Despite this,
implementation of best practices including protocolized severe sepsis care and
initial post-cardiac management bundles, has been inconsistent. Only 25% of
providers, and only a third of hospitals, report implementing therapeutic
hypothermia (TH) as part of post-cardiac arrest care [9] [13] [14]. Similarly,
implementation of EGDT has been poor with only 7% of academic emergency
departments (EDs) reporting EGDT as standard treatment in 2005 [15]. A 2010
survey of Pennsylvania EDs reported only 2/3 performing EGDT “more often than
not”, and even specialized tertiary care facilities with international expertise in
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sepsis care have reported EGDT utilization rates of 58% for EGDT-eligible
patients [13] A 5-fold regional variation in survival (3–16.3%) has been observed
for OHCA in US cities [1], a component of which can be attributed to the quality of
post-arrest care, and similar variability has been described for sepsis outcomes
[16].
Real time near continual assessment of resuscitation endpoints is the new paradigm
for both OHCA and severe sepsis, and this resuscitation strategy was integrated
into both the American Heart Association’s and Surviving Sepsis Campaign’s
initial resuscitation management bundles [5] [17]. Given the burden of these
diseases, the time-sensitive nature of care, and recognized knowledge gaps,
alternatives are needed in order to provide appropriate, evidence-based care for
patients. Potential barriers include: knowledge gaps, provider staffing, and lack of
access to subspecialty consultants [18, 19, 20, 21]. One method of overcoming
barriers to implementation is the early involvement of a resuscitation expert.
Telemedicine has proven to be a versatile, effective, and efficient platform for real-
time support and consultative services for patients suffering from acute ischemic
strokes in rural EDs [22] [23], however ED-based applications outside of this
setting have not been tested. In the Telemedicine REsuscitation and Arrest Trial
(TREAT), we sought to determine the feasibility of a real time provider-to-
provider telemedical intervention for the treatment of critically ill post-arrest and
severe sepsis patients within the ED.
2. Materials and methods
2.1. Study design and setting
TREAT is a pilot study performed in three affiliated hospitals within a health
system including a large referral academic medical center and two academic
affiliates. A “hub-spoke model” was created with the academic medical center
acting both as the hub for telemedical consultation for all three hospitals as well as
a spoke hospital enrolling patients. The “hub” institution has an annual volume of
66,440 patients with an average of 22% admission rate. The two affiliated centers
(“spokes”) treat between 34,000 and 38,000 patients per year and, when needed,
transfer patients to the hub institution. The study took place over a twelve week
time period (03/2013-06/2013). The study was approved by the Institutional
Review Board at the University of Pennsylvania and deemed exempt from
informed consent, as on-call providers would otherwise be involved with the
patient care at baseline. All on-call providers are credentialed in all three EDs and
each ED utilized the same, remotely accessible, electronic medical record (EMR).
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2.2. Patient identification and selection
Eligible patients were adults (>18 years of age) presenting to one of the three EDs
with either ROSC following OHCA or with severe sepsis or septic shock [4].
Automated text messages linked to the ED EMR alerted on-call telemedical
consultants of all patients with serum lactate levels ≥4 mmol/L or “cardiac arrest” as
the presenting complaint in real-time (Fig. 1). Bedside clinicians in the ED
determined when telemedical consultation would be initiated based on inclusion
criteria for severe sepsis/septic shock or induction of therapeutic hypothermia as
defined by current literature and local practices (Fig. 4 and Fig. 2). The protocol
developed for this feasibility trial was built in conjunction with the local ED teams
and the emphasis was to have teleconsultation triggered by the bedside clinician at
their discretion. Although serum lactate and EMR compliant of “cardiac arrest” were
automated alerts, allowing telemedical consultants to know if a potential case was
present, ultimately, the decision to call the telemedical consultants was at the
discretion of the clinical management team.
2.3. Telemedicine equipment
A mobile, wirelessly connected, HIPAA compliant, commercially available
telemedical cart (developed by a private telemedical vendor) was placed in the
[(Fig._1)TD$FIG]
Fig. 1. Telemedical Consultation Flow Diagram. Flow diagram followed to initiate teleconsultation.
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ED of all three hospitals (Fig. 3). Each cart was equipped with a computer with
telemedical software, two large (front and back facing) flat panel high definition
monitors, pan/tilt/zoom video camera, speaker, and microphone. On-call telemed
consultants were supplied with a wirelessly connected laptop, headphones, and
mobile hotspot to ensure Internet connectivity 24 h a day, 7 days a week. The on-
call team consisted of four attending emergency physicians, two clinical nurse
specialists, and a research coordinator.
[(Fig._2)TD$FIG]
Fig. 2. Early Goal-Directed Therapy Flow Sheet.
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2.4. Telemedical consultation
All on-call physicians, nurses, and ED nurses and paramedics received training
on the use of the telemedical cart by the project manager at the outset of the
study. On-call providers also received training on how to access the cart remotely
using the telemedical software. When deemed appropriate by the ED clinical
team as describe above, a telemedical consultation was initiated by placing the
[(Fig._3)TD$FIG]
Fig. 3. Therapeutic Hypothermia Flow Sheet.
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telemedical cart in the patient ED room and logging into the system. The creation
of this consult automatically sent a text message alert to the on-call telemed team,
allowing them to enter the patient encounter from their remote location (Fig. 1).
As soon as the on-call provider was available, a real-time audiovisual connection
was established giving patients, family members, nursing staff, and physicians
(residents and attendings depending on the site) the ability to communicate with
the remotely located resuscitation physician. Both the local ED provider and the
remote physician had the ability to control the video camera located in the patient
ED room − allowing for the remote provider to visually assess the patient,
examine in-room monitors and procedures, and speak face to face with anyone in
the patient room.
2.5. Data collection and analysis
Separate standardized data collection sheets were created for EGDT- and TH-
eligible patients (Appendix A in Supplementary material). Each telemedical patient
[(Fig._4)TD$FIG]
Fig. 4. Telemedical Cart. Still image of telemedical cart.
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encounter was monitored for connection times, number of connection attempts,
disconnections, and quality of audiovisual connection. Patient level data
(demographics, physiologic, laboratory, and treatment data) was abstracted from
the ED EMR. Variables included age, gender, vital signs, EGDT parameters (mean
arterial pressure [MAP], central venous pressure [CVP], central venous oxygen
saturation [SCVO2], urine output), serum lactate levels, prehospital cardiac arrest
data (location, bystander CPR, initial cardiac rhythm, automated external
defibrillator [AED] application, defibrillation, epinephrine administration), time-
stamps of telemedical connection, time of clinical interventions, clinical decision-
making, and assessment of audiovisual connection. Data were entered into an
Excel spreadsheet (Version 14.6; Microsoft Corporation, Redmond, Washington)
and descriptive statistics were performed. Results were reported as numbers and
percentages for demographic data such as age and sex of study subjects and as
mean ± standard deviation (mean ± S.D) for descriptive data.
2.6. Assessment of technological and practical feasibility
The aim of the TREAT study was to assess the technological feasibility of
performing real-time telemedical consultation for the treatment of critically ill
patients within the ED. A key component to the delivery of telemedical care is
reliable technology and connectivity. The specific objective endpoints were: time
to established telemedical connection with on-call team, number of connection
attempts and number of unintentional disconnections. At the end of each
consultation patients, ED staff, and the remote clinical were asked to rate the
audio and visual connection. Adequacy of patient selection for EGDT or post-
cardiac TH was determined via chart review and expert adjudication. Adequacy of
patient management was determined using time-sensitive guidelines set forth by
the Surviving Sepsis Campaign and the American Heart Association.
3. Results
Over a 12-week period, there were 80 automated text alerts (38 “cardiac arrest,” 42
“lactate ≥4 mmol/L”). Of the 38 cardiac arrest automated text alerts, 13 achieved
ROSC (34.2%), 11 underwent telemedical consultation (84.6% with ROSC); 69.2%
were TH-eligible. During the study period, 14 (33.3%) patients with a serum lactate
>4 mmol/L were determined to have severe sepsis or septic shock and underwent a
telemedical consultation.
Characteristics and descriptive statistics of patients undergoing telemedical
consultation for post-cardiac arrest care and severe sepsis/septic shock are shown
in Table 1 and Table 2. Mean age for post cardiac arrest patients was 52.2 years.
The majority of cases were found to have a prehospital cardiac rhythm of asystole
(54.5%), be witnessed events (72.7%), and had EMS administered epinephrine
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(63.6%). Mean age for severe sepsis/septic shock patients undergoing telemedical
consultation was 69.1 years. Average initial lactate was found to be 5.4 mmol/L
(95% CI 3.1–7.7), an average of 2100 mL (95% CI 1404.4–2795.6) of IVF was
given during the ED stay, and mean repeat lactate was 3.7 mmol/L (95% CI
2.1–5.3). Mean times from triage to critical interventions were: initial lactate 67.8
min (13.9–121.7), IVF 66.3 min (40.5–92.1), and antibiotics 121.6 min
Table 1. Post Cardiac Arrest Consultations.
Male %/SD Female %/SD Total %/SD
Demographics
Cases (n) 8 63.6 3 36.4 11 100.0
Age (mean) 53.1 17.7 49.6 14.2 52.2 16.1
Event Location (%)
Private Residence 6 75.0 1 33.3 7 63.6
Nursing Home 1 12.5 1 33.3 2 18.2
Other 1 12.5 1 33.3 2 18.2
Post ROSC Vital Signs: Mean (SD)
Heart rate 113 60 115 49 114 40
Systolic Blood Pressure 106 17 130 71 113 40
Diastolic Blood Pressure 63 21 73 34 66 24
Mean Arterial Pressure 76 18 92 46 81 28
Oxygen Saturation 90 12 80 17 86 14
Prehospital Care (%)
Initial Cardiac Rhythm: Asystole 6 75.0 1 33.3 7 54.5
Witnessed Event 5 62.5 3 100.0 8 72.7
Bystander CPR 1 12.5 1 33.3 2 18.2
Bystander AED use 0 0.0 0 0.0 0 0.0
EMS Defibrillation 1 12.5 1 33.0 2 18.2
# of Defibrillations: Mean (SD) 0.1 0.4 0.5 1.0 0.3 0.7
EMS Epinephrine 4 0.0 3 100.0 7 63.6
# of Epinephrine: Mean (SD) 1.6 1.5 1.5 1.3 1.5 1.4
Therapeutic Hypothermia Management (%)
Initiated (%) 6 71.4 3 100.0 9 81.8
ROSC: return of spontaneous circulation, AED: automated external defibrillator.
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(78.8–164.4, Table 3). All TH-eligible cases utilized telemedicine and induction of
TH was started during the consult.
Table 3 reveals telemedicine connection times and connection rating. Average time
from OHCA teleconsultation request to live telemedical connection was short (3.7
min, 95% CI 1.6–5.8). Mean call duration was 71.7 min (95% CI 34.6–108.8).
Mean number of connection attempts was 1.1 (secondary to failed login attempts
from consultant), with no complete disconnections. Sepsis teleconsultations had a
mean time to connection of 8.4 min (95% CI 4.5–12.3), call duration of 61.5 min
(95% CI 37.2–85.8), and mean number of connection attempts 1.1 and
disconnection 0.2 per call.
Table 2. Severe Sepsis Consultations.
Male %/SD Female %/SD Total %/SD
Demographics
Cases (n) 7 50 7 50 14 100
Age: mean (SD) 67.3 24.9 70.6 24.9 69.1 20.8
Vital Signs: Mean (SD)
Max Temperature (F) 101.6 2.6 99.9 2.6 100.6 2.8
Max HR 120 19 113 19 116 21
Max RR 29 3 22 3 23 6
Low MAP 76 21 78 21 77 18
Patient Management
Initial Lactate (mmol/L) 4.1 5.6 6.5 5.7 5.4 4.4
IVF (mL) 1,925 1,687 2,251 1,687 2,100 1,328
Repeat Lactate (mmol/L) 3.3 4.1 4.1 4.1 3.7 3.1
Time to Lactate (min) 98.8 32 36.9 32.5 67.8 102.9
Time to IVF (min) 43.6 50.1 85.7 50.1 66.3 49.3
Time to Antibiotics (min) 115.7 46.6 127.6 46.6 121.6 81.7
Time to Central Access (min)* 104.6 71.4 222.5 71.4 172.1 88.1
Time to Vasopressor (min)* 121 – 310 – 168.3 133
Early Goal Directed Therapy
Initiated (%) 7 100 7 100 14 100
HR: Heart Rate, RR: Respiratory Rate, MAP: Mean Arterial Pressure, IVF: IV fluid.
* Limited values reported in electronic medical record.
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Consultants, ED staff, and patients ranked ability to see and hear the consultant or
ED team on a Likert scale (1 = strongly disagree, 5 = strongly agree). Table 3
displays results, overall consultants consistently ranked ability to see and hear for
both disease states highly (4.6–5.0 on Likert scale), with staff and patients ranking
their ability to see and hear the consultant similarly (4.5–4.9).
4. Discussion
We piloted a provider-to-provider hub-spoke telemedical network with 24 h on-call
resuscitation specialists available for teleconsultation regarding the assessment and
initiation of proven resuscitation bundles for critically ill patients within the ED.
We demonstrate the feasibility of using real time ED-based “telemedical
consultation” or “telementoring” for the care of critically ill patients presenting
to the ED with either ROSC after OHCA or severe sepsis/septic shock.
Telemedicine provides a robust and reliable means of quickly bringing expertise
virtually to the bedside at the most proximal point in a patient’s care in the ED and
has the potential to improve the dissemination and implementation of evidence
based best clinical practice in this population.
Telemedicine may offer a novel solution to improving the dissemination of medical
expertise and knowledge and thus impact patient care − allowing clinical
experience and knowledge only available in a limited number of centers to reach
community, remote, or rural hospitals. Telemedicine has evolved from the
relatively simple “store and forward” concept used to transmit images to remotely
Table 3. Telemedical Consultations.
OHCA Severe Sepsis
Telemedical Consultations (n) 11 14
Connection Time (min) 3.7 8.4
Consult Duration (min) 71.7 61.5
Connection Attempts 1.1 1.1
Disconnections 0 0.2
Mean Rating (SD)
Consultant ability to SEE 5.0 (0) 4.6 (1.1)
Consultant ability to HEAR 4.7 (0.5) 4.6 (1.1)
Staff/Patient ability to SEE 4.9 (0.3) 4.5 (1.1)
Staff/Patient ability to HEAR 4.8 (0.4) 4.5 (1.1)
Likert Rating: 5 = Strongly Agree, 1 = Strongly Disagree. All values reported as means unless
otherwise noted.
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located specialists, to more sophisticated real-time high resolution video
conferencing that allows an individual to be at the bedside in a matter of minutes.
There has been a call for further, expanded applications of telemedicine in the ED,
the American College of Emergency Physicians (ACEP) states, “the ED may be an
ideal place for telemedicine . . . ” and claimed significant applications for
telemedicine in the ED for “decision-making aids, remote sensing (or sharing
images between healthcare centers), and collaborative real-time patient manage-
ment [24].” EDs have slowly expanded the applications of telemedicine, now
working as a means to improve access to sub-specialty services such as
dermatology and psychiatry − services traditionally known for high demand,
low supply cultures, but little has been done to test the ability to utilize
telemedicine for real time teleconsultation in order to improve outcomes for the
critically ill patient.
Several studies have demonstrated the importance of not only earlier recognition of
disease processes but also early and aggressive resuscitation [2] [3] [5] [8, 9, 10, 11,
12]. EDs continue to care for an increasing number of patients who may potentially
benefit from aggressive therapies such as TH and protocolized sepsis resuscitation
[25, 26, 27, 28, 29]. Despite advancements in early diagnostics (i.e. triage serum
lactate screening), mortality remains high [30]. Telemedicine offers the tools needed
to quickly involve a critical care specialist early on in the disease progression. The
data from this study show that a remotely connected specialist was able to connect and
interact with the patients and ED staff within 5–10 min despite their varied locations
in the world at the time of teleconsultation request.
We found that telemedicine offered the capability for both the remote physician
and the ED staff to interact clearly and without disturbance. Initiation of
protocolized care occurred in all eligible patients utilizing telemedicine.
Telemedicine may offer the means for improved clinical decision-making and
the uptake of evidence-based care [31, 32, 33, 34, 35]. Based on the interactions
we observed during the study period, we believe telemedicine allows for an
additional expert to become an instant part of the patient care team. Our team was
able to remotely diagnose, adjust, and trouble shoot patient care devices such as the
TH cooling wraps, mechanical ventilators, IV medications, and to observe and
supervise procedures. Telemedicine also allowed for the patient and family
members to have one-on-one access to a resuscitation expert in the middle of a
busy and crowded ED during any time of day or night. This pilot briefly revealed
provider and patient comfort with the communication modality and anecdotally
patients and their families expressed relief in knowing they (or their loved one) was
being closely monitored. In-house providers brainstormed about future uses
including the potential of using the platform for a “telementoring” means of
delivering bedside teaching and continuing medical education (CME), which to our
knowledge, does not exist.
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The TREAT study has several limitations. The study was conducted within one
health system and only within three hospitals of varying capacities and therefore
may not be generalizable to other hospital systems. All on-call providers were
credentialed at each hospital and were familiar with both the staff and EMR, thus
this study avoided the complications of provider credentialing, malpractice, and
payment schedules. Though the on-call providers were credentialed at each
hospital and members of the academic faculty, in-house ED staff often expressed
concern over who was ultimately managing the patient’s care. To address this
concern, this pilot was aimed at feasibility and thus deferred final management
guidelines to the in-house physician. The hub institution also has a Center for
Resuscitation Science dedicated to improving ED-based resuscitation care and
aggressive TH and EGDT programs. Further, the study was conducted over a
brief, 12-week-long period and only enrolled 25 patients. However, the study’s
primary aim was not to analyze patient outcomes or specific details of clinical
care but to examine the feasibility of using an innovative telemedicine platform to
connect remote providers, ED providers, patients, and family members. Finally,
though we found during the course of the study that we were able to adjust and
trouble shoot patient care devices such as cooling wraps, arterial lines, and
mechanical ventilators, these troubleshooting abilities were not anticipated a
priori and outcomes were not hypothesized prior to study initiation.
5. Conclusions
The TREAT study reveals the practical feasibility of using teleconsultation for
post-arrest and septic shock patients. In this trial, telemedicine was a reliable
means of virtually connecting a provider with the bedside team within minutes.
TREAT sheds light on the future of connected health care delivery for critical
illness, dissemination and implementation of evidence-based care, and the way we
approach the care for unplanned critical illness within the ED. In TREAT-2, our
future plan is to evaluate the impact of using telemedical consultation on the
adherence to best practices and patient outcomes for post-arrest and septic shock
patients in the ED. Further analysis should also focus on the impact of telemedicine
on hospital level factors such as costs, staffing and patient flow.
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